Patent application number | Description | Published |
20110045067 | SOFT GEL CAPSULES - The invention relates to soft gelatin capsules containing at least one pharmaceutical, wherein the capsule shell includes carrageenan and cold water fish gelatin or a mixture of cold fish gelatin and warm fish gelatin. | 02-24-2011 |
20110268770 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a statin within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion, one or both of the oil phase and the water phase whereof comprises a physiologically tolerable omega-3 acid ester. | 11-03-2011 |
20110268771 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion. | 11-03-2011 |
20130273025 | ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS - This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs. | 10-17-2013 |
20140005179 | ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS | 01-02-2014 |
20140163108 | ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS - The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic. | 06-12-2014 |
20150037438 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion. | 02-05-2015 |
Patent application number | Description | Published |
20090010914 | Use of Oligouronates for Treating Mucus Hyperviscosity - The invention provides a method of treatment of a human or non-human subject to combat mucosal hyperviscosity in the respiratory tract, which method comprises application to a mucosal surface in said tract in said subject of an effective amount of a physiologically tolerable oligouronate. | 01-08-2009 |
20090220576 | EMULSION - The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester. | 09-03-2009 |
20090238866 | CHEWABLE CAPSULES - The invention provides an orally administrable chewable capsule comprising a capsule shell enclosing an oil-in-water emulsion in which the aqueous phase is gelled, or an oil droplet-containing dried residue of such an emulsion. | 09-24-2009 |
20120076853 | COMPOSITION FOR USE IN GENE THERAPY - A composition useful in gene therapy and a method of treatment to effect gene therapy is provided. In particular, a parenteral pharmaceutical gene therapy composition comprising a non-immunogenic net polyanionic oligosaccharide associated with a particulate complex of an anionic nucleic acid material and a cationic macromolecule, optionally together with at least one pharmaceutical carrier or excipient, is provided. | 03-29-2012 |
20120100210 | COMPOSITION FOR THE ADMINISTRATION OF POLYMERIC DRUGS - Provided are improvements in and relating to pharmaceutical compositions for oral administration of polymeric biological drug substances and to methods of treatment using such compositions. In particular, an oral and/or mucosal pharmaceutical composition is provided, said composition comprising an enteric-coated drug substance, and also comprising an enteric-coated oligouronate, wherein said drug substance is a polymeric biological drug substance. | 04-26-2012 |